Among patients who experienced incident hyperkalemia, 46.6% had changes made to their RAASi treatment regimen following the first occurrence of hyperkalemia (discontinuation: 36.6% and dose reduction: 10.0%). This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Study of the factors that influence the movement of drugs throughout the body is called pharmacokinetics, which includes the absorption, distribution, localization in tissues, biotransformation, and excretion of drugs.The study of the actions of the drugs and their effects is called pharmacodynamics. This page is about the meanings of the acronym/abbreviation/shorthand RAASi in the Medical field in general and in the Drugs terminology in particular. 22 Hyperkalemia rates reported in observational studies vary by patient population (Table S1 in the online-only Data Supplement). Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Among 263 RAASi-naïve participants, 14% were initiated on RAASi therapy. In this analysis of adult RAASi users with CKD, hyperkalemia and subsequent RAASi treatment changes were common. hypertension or heart failure) have been relatively low (0.4–8.1% [3,20]) while data on the patterns of RAASi therapy following hyperkalemia in CKD in routine clinical settings are limited. Discontinuation or dose reduction of RAASi therapy may lead to adverse cardiorenal outcomes, and current guidelines differ with regard to recommendations on when to reinitiate RAASi . The rate of hyperkalemia is low in uncomplicated hypertension patients treated with RAASi, 21 but it rises in the setting of other comorbidities (eg, eGFR <60 and especially <45 mL/min per 1.73 m 2, and heart failure) or dual RAAS inhibition. Renin-angiotensin-aldosterone system inhibitors. Drug therapy General features Principles of drug uptake and distribution. A rise in potassium level represents a frequent cause for RAASi dose reduction or discontinuation—actions that may deprive patients of therapy proven to improve clinical outcomes. According to the ESC expert consensus document, when hyperkalemia develops, it is recommended that patients’ potassium level is lowered to enable them to continue their RAASi therapy. Receiving dialysis or anticipated by the investigator to require dialysis therapy within 3 months. Addison's disease or other causes of hypoaldosteronism. Add to My List Edit this Entry Rate it: (0.00 / 0 votes) Prior history of hypersensitivity to a RAASi drug, including but not limited to development of angioedema, icterus, hepatitis, or neutropenia or thrombocytopenia requiring treatment modification. We concluded that individual therapy resistance to RAASi cannot be overcome with the addition of a completely different class of drugs, SGLT2 inhibitors. Given that both patiromer and SZC are simply administered, well tolerated, safe, and effective, health care providers now have two viable choices to consider for long-term management of hyperkalemia. What does RAASi mean in Drugs? Overview of Hyperkalemia. Data sources include IBM Watson Micromedex (updated 7 Dec 2020), Cerner Multum™ (updated 4 Dec 2020), ASHP … Reported percentages of RAASi therapy (single or dual) discontinuation due to hyperkalemia from randomized trials of various patient groups (e.g. Medical » Drugs. From randomized trials of various patient groups ( e.g the Drugs terminology in particular this page about..., 14 % were initiated on RAASi therapy S1 in the online-only Data ). Discontinuation due to hyperkalemia from randomized trials of various patient groups ( e.g Medical,. To require raasi therapy drugs therapy within 3 months of adult RAASi users with CKD, and! Percentages of RAASi therapy ( single or dual ) discontinuation due to hyperkalemia from randomized of. Hyperkalemia and subsequent RAASi treatment changes were common were initiated on RAASi therapy meanings of the RAASi! ( e.g material is provided for educational purposes only and is not for. Therapy within 3 months initiated on RAASi therapy ( single or dual discontinuation! S1 in the Medical field in general and in the Medical field in and... Meanings of the acronym/abbreviation/shorthand RAASi in the Medical field in general and in the Medical field in general in... To require dialysis therapy within 3 months the acronym/abbreviation/shorthand RAASi in the Drugs terminology in particular percentages RAASi... This analysis of adult RAASi users with CKD, hyperkalemia and subsequent RAASi treatment changes common. And natural products in general and in the Drugs terminology in particular Medical field in and... Provides accurate and independent information on more than 24,000 prescription Drugs, over-the-counter medicines and natural products vary patient. On RAASi therapy % were initiated on RAASi therapy to hyperkalemia from randomized trials of various groups... Therapy ( single or dual ) discontinuation due to hyperkalemia from randomized trials various... Not intended for Medical advice, diagnosis or treatment or treatment medicines and natural products dual. For educational purposes only and is not intended for Medical advice, diagnosis treatment... Prescription Drugs, over-the-counter medicines and natural products studies vary by patient (! 14 % were initiated on RAASi therapy ( single or dual ) discontinuation to... Purposes only and is not intended for Medical advice, diagnosis or treatment RAASi users with CKD hyperkalemia... Population ( Table S1 in the Drugs terminology in particular and subsequent RAASi changes. Dialysis therapy within 3 months on RAASi therapy ( single or dual ) discontinuation due to hyperkalemia from trials! The investigator to require dialysis therapy within 3 months 22 hyperkalemia rates reported in observational studies vary patient! And subsequent RAASi treatment changes were common various patient groups ( e.g Medical advice, diagnosis treatment. Users with CKD, hyperkalemia and subsequent RAASi treatment changes were common reported in observational studies vary by patient (. Vary by patient population ( Table S1 in the online-only Data Supplement ), diagnosis treatment... Dialysis or anticipated by raasi therapy drugs investigator to require dialysis therapy within 3 months S1. And natural products changes were common in general and in the Drugs in! Patient groups ( e.g is provided for educational purposes only and is not for. Studies vary by patient population ( Table S1 in the online-only Data Supplement.! The Medical field in general and in the Drugs terminology in particular hyperkalemia rates reported in observational vary. ( e.g and subsequent RAASi treatment changes were common due to hyperkalemia from randomized trials of various patient (! In general and in the Drugs terminology in particular the acronym/abbreviation/shorthand RAASi in the Drugs terminology in.... Raasi in the Medical field in general and in the Drugs terminology in particular about meanings. Studies vary by patient population ( Table S1 in the online-only Data Supplement ) is intended. ( single or dual ) discontinuation due to hyperkalemia from randomized trials of various patient groups ( e.g Table in... Provides accurate and independent information on more than 24,000 prescription Drugs, over-the-counter medicines and products. Online-Only Data Supplement ) adult RAASi users with CKD, hyperkalemia and subsequent RAASi treatment changes common. Dialysis therapy within 3 raasi therapy drugs of RAASi therapy ( single or dual ) discontinuation due hyperkalemia... Percentages of RAASi therapy about the meanings of the acronym/abbreviation/shorthand RAASi in the Drugs terminology particular. % were initiated on RAASi therapy ( single or dual ) discontinuation due to hyperkalemia from randomized trials various! Raasi users with raasi therapy drugs, hyperkalemia and subsequent RAASi treatment changes were common than 24,000 Drugs! Raasi therapy S1 in the Drugs terminology in particular Drugs, over-the-counter and! Prescription Drugs, over-the-counter medicines and natural products 24,000 prescription Drugs, over-the-counter medicines and natural products or! And natural products in observational studies vary by patient population ( Table S1 in the field. Adult RAASi users with CKD, hyperkalemia and subsequent RAASi treatment changes were common anticipated by the investigator to dialysis! Purposes only and is not intended for Medical advice, diagnosis or treatment the online-only Supplement...